IVA: Inventiva S.A.
Performance
IVA -4.24%
Watchlist
Select an item
Summary
IVA at a glance
IVA returned -4.24% over the past year and -23.12% a year over five years. Its worst drop in that year was -59.86%, smaller than 13% of stocks on Redstone, and its Sharpe ratio of 0.20 beats 36% of stocks on Redstone. It pays no dividends.
Current Drawdown
-46.29%
Rolling Volatility
74.29%
Actions
Metrics
Risk Indicators
Alpha4.12%
Beta0.91x
Sharpe0.20
Sortino0.31
Omega1.03
Calmar-0.07
Martin0.41
Profile
About IVA
Inventiva SA is a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of metabolic dysfunction-associated steatohepatitis (MASH) and other diseases with unmet medical needs.
- Sector
- Health Care
- Market cap
- $907M
- Listed
- Jul 2020
- Employees
- 77
- Website
- inventivapharma.com
Comparisons